MAFLD: Now is the time to capitalize on the momentum
This study in concert with a recent statement by>30 patient advocacy associations led by the European Liver Patients' Association (ELPA) and associations across different disciplines from diabetes to renal medicine and obesity medicine across the globe, highlights the increasing traction that MAFLD has received [7].
Source: Journal of Hepatology - Category: Gastroenterology Authors: Mohammed Eslam, Jacob George Tags: Letter to the Editor Source Type: research
More News: Diabetes | Eating Disorders & Weight Management | Endocrinology | Gastroenterology | Liver | Obesity | Study | Urology & Nephrology